{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:02:00Z","timestamp":1767902520973,"version":"3.49.0"},"reference-count":19,"publisher":"Microbiology Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:p>Diagnostic, genotypic and antibiotic-resistance determinants of<jats:italic>Neisseria gonorrhoeae<\/jats:italic>were analysed by molecular methods to verify the failure of ceftriaxone treatment in two cases of pharyngeal gonorrhoea. Monoplex assays were needed to define competitive inhibition of a positive<jats:italic>Chlamydia<\/jats:italic>PCR in a duplex assay. Different<jats:italic>penA<\/jats:italic>changes were detected in the<jats:italic>N. gonorrhoeae<\/jats:italic>isolated from the two cases. These were associated with raised ceftriaxone MICs of 0.03 and 0.016\u2005mg\u2005l<jats:sup>\u22121<\/jats:sup>, which may have contributed to the treatment failures in these cases.<\/jats:p>","DOI":"10.1099\/jmm.0.007641-0","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T17:38:13Z","timestamp":1239817093000},"page":"683-687","source":"Crossref","is-referenced-by-count":100,"title":["Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods"],"prefix":"10.1099","volume":"58","author":[{"given":"John","family":"Tapsall","sequence":"first","affiliation":[{"name":"World Health Organization Collaborating Centre for STD, Prince of Wales Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Read","sequence":"additional","affiliation":[{"name":"Sydney Sexual Health Centre, Sydney Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Carmody","sequence":"additional","affiliation":[{"name":"Short Street Sexual Health Clinic, St George Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bourne","sequence":"additional","affiliation":[{"name":"Sydney Sexual Health Centre, Sydney Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghamitra","family":"Ray","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for STD, Prince of Wales Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena","family":"Limnios","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for STD, Prince of Wales Hospital, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Sloots","sequence":"additional","affiliation":[{"name":"Queensland Paediatric Infectious Diseases Laboratory, Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital and Health Service District, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Whiley","sequence":"additional","affiliation":[{"name":"Queensland Paediatric Infectious Diseases Laboratory, Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital and Health Service District, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at 6-h interval","volume":"9","author":"Deguchi","year":"2003","journal-title":"J Infect Chemother"},{"key":"R2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.diagmicrobio.2007.12.007","article-title":"A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes","volume":"61","author":"Goire","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","article-title":"Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan","volume":"49","author":"Ito","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R4","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure in Neisseria gonorrhoeae infection","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R5","first-page":"E070201","article-title":"An investigation to determine if newly-discovered variant of Chlamydia trachomatis is present in Ireland","volume":"12","author":"Lynagh","year":"2007","journal-title":"Euro Surveill"},{"key":"R6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/383047","article-title":"Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area","volume":"189","author":"Martin","year":"2004","journal-title":"J Infect Dis"},{"key":"R7","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/AAC.45.12.3603-3606.2001","article-title":"Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan","volume":"45","author":"Muratani","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1442-2042.2008.02100.x","article-title":"Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae","volume":"15","author":"Muratani","year":"2008","journal-title":"Int J Urol"},{"key":"R9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","article-title":"Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone","volume":"14","author":"Osaka","year":"2008","journal-title":"J Infect Chemother"},{"key":"R10","first-page":"E061109","article-title":"A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use in PCR diagnostic tests","volume":"11","author":"Ripa","year":"2006","journal-title":"Euro Surveill"},{"key":"R11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1258\/095646207781568556","article-title":"Pharyngeal gonorrhoea \u2013 is dual treatment the way forward?","volume":"18","author":"Sathia","year":"2007","journal-title":"Int J STD AIDS"},{"key":"R12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jac\/45.6.909","article-title":"Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis","volume":"45","author":"Simmons","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"R13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00313029500169492","article-title":"The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhoea","volume":"27","author":"Tapsall","year":"1995","journal-title":"Pathology"},{"key":"R14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10096-004-1170-0","article-title":"A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene","volume":"23","author":"Whiley","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/00313020701444515","article-title":"Use of a novel screening PCR indicates presence of Neisseria gonorrhoeae isolates with a mosaic penA gene sequence in Australia","volume":"39","author":"Whiley","year":"2007a","journal-title":"Pathology"},{"key":"R16","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/AAC.00306-07","article-title":"Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone","volume":"51","author":"Whiley","year":"2007b","journal-title":"Antimicrob Agents Chemother"},{"key":"R17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1071\/SH07050","article-title":"Exploring \u201cbest practice\u201d for nucleic acid detection of Neisseria gonorrhoeae","volume":"5","author":"Whiley","year":"2008","journal-title":"Sex Health"},{"key":"R18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","article-title":"Emerging antimicrobial resistance in Neisseria gonorrhoeae : urgent need to strengthen prevention strategies","volume":"148","author":"Workowski","year":"2008","journal-title":"Ann Intern Med"},{"key":"R19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.007641-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T23:48:44Z","timestamp":1739058524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.007641-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.007641-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,1]]}}}